We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Acute coronary syndrome (ACS)
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Acute coronary syndrome (ACS) refers to a group of conditions due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. It encompasses a range of sudden heart conditions, including heart attack and unstable angina attack (sudden chest pain). ACS mainly happens due to narrowing of the blood vessels which supply the heart due to a build-up of plaque (a fatty, sticky substance) on the walls of arteries. The GRACE risk score tool is a special tool which can be used by healthcare professionals (such as doctors) to calculate the risks of further heart attack or death after acute coronary syndrome (type of unstable angina attack or heart attack), by looking at medical information that is routinely collected during hospital stays. The aim of this study is to find out whether there is a difference in patient’s health status following an unstable angina attack or a heart attack if treated according to usual care or if treated using the GRACE risk score tool.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2019 Protocol article in https://bmjopen.bmj.com/content/9/9/e032165.info (added 12/08/2022)2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37315959/ (added 15/06/2023)
You can take part if:
You may not be able to take part if:
Research sites exclusion criteria:GRACE risk tool already implemented.
Patient exclusion criteria:1. Patients presenting at hospital due to an acute ST-segment elevation myocardial infarction (STEMI)2. Patients presenting at hospital with an ACS accompanied with, or precipitate by significant co-morbidity e.g. motor vehicle accident, trauma, severe gastrointestinal bleeding3. Peri-operative or peri-procedural MI4. Patients already recruited into the study
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Ms
Rachael
Gilberts
+44 113 343 0254
R.M.Gilberts@leeds.ac.uk
The study is sponsored by University of Leeds and funded by British Heart Foundation.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 32356
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
